サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：肝転移治療薬の世界市場規模調査＆予測、原発がん別、タイプ別、流通チャネル別、地域別分析、2022-2029年
市場調査レポート
商品コード
1251569

肝転移治療薬の世界市場規模調査＆予測、原発がん別、タイプ別、流通チャネル別、地域別分析、2022-2029年

Global Liver Metastases Treatment Market Size study & Forecast, by Type by Primary Cancer, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
肝転移治療薬の世界市場規模調査＆予測、原発がん別、タイプ別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年03月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肝転移治療薬市場は、2021年に約12億米ドルと評価され、予測期間2022-2029年には7.2％以上の健全な成長率で成長すると予測されています。

肝転移は、もともとの腫瘍やがんから肝臓に転移するものです。肝転移は肝臓から始まるのではなく、他の患部から広がっていくものです。肝臓に転移したがんは、肝転移を引き起こします。肝転移の治療とは、肝転移を治すために用いられる方法です。肝臓に転移する代表的ながんには、乳がん、大腸がん、食道がん、肺がんなどがあります。乳がんや大腸がんの症例数の増加、がん治療に対する政府の支援や取り組みの増加、研究開発の進展、対象疾患の発生率の上昇などが、市場の成長を促す要因となっています。

世界がん研究基金によると、2020年の世界の乳がん患者数は約12.5％であるのに対し、肺がん患者数は同約12.2％となっています。2020年の新規症例数は190万人で、大腸がんは全がん種の中で3位、全症例の10.7％を占めています。さらに、世界保健機関は2040年までに乳がんによる死亡を250万人防ぐという目標を達成するため、2023年2月に新たな世界乳がん対策の枠組みを発表しました。乳がんや大腸がんの症例が増加していること、政府の支援やイニシアチブが増加していることは、市場の成長を促す主な要因となっています。その他、研究開発の進展や対象疾患の罹患率の上昇も、市場拡大を牽引する重要な要素となっています。肝転移治療における技術的進歩やヘルスケアにおける研究開発の増加は、予測期間中に大きな市場機会を生み出しています。しかし、肝転移治療薬の高コストが、2022年から2029年の予測期間を通じて市場成長を阻害します。

肝転移治療薬の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、がんに対する先進的な治療オプションの利用可能性、がんに対する有利な政府政策、米国などの国における肝転移の高い有病率により、収益面で市場を独占しています。例えば、米国では年間約14万件の肝転移症例があると言われています。アジア太平洋地域は、医療費の増加、医療施設へのアクセスの容易さ、効果的なスクリーニングの欠如などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 肝転移治療薬市場、地域別、2019-2029年
    • 肝転移治療薬市場、タイプ別、2019-2029年
    • 肝転移治療薬市場、原発がん別、2019-2029年
    • 肝転移治療薬市場、流通チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の肝転移治療薬市場の定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 肝転移治療薬の世界市場力学

  • 肝転移治療薬市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 乳がん、大腸がんの患者数の増加
      • がん治療における政府の支援や取り組みの増加
    • 市場の課題
      • 肝転移の治療費が高い
    • マーケットオポチュニティ
      • 肝転移治療における技術の進歩
      • ヘルスケアにおける研究開発の活発化

第4章 肝転移治療薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 投資採用モデル
  • アナリストの提言と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスクアセスメントCOVID-19の衝撃

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 肝転移治療薬の世界市場：タイプ別

  • マーケットスナップショット
  • 肝転移治療薬の世界市場：タイプ別、性能別- ポテンシャル分析
  • 肝転移治療薬の世界市場タイプ別推定・予測2019-2029
  • 肝転移治療薬市場、サブセグメント別分析
    • 化学療法
    • 標的療法
    • 免疫療法

第7章 肝転移治療薬の世界市場：原発がん別

  • マーケットスナップショット
  • 肝転移治療薬の世界市場：原発がん別、性能別）-ポテンシャル分析
  • 肝転移治療薬の世界市場原発がん別推定・予測2019-2029
  • 肝転移治療市場、サブセグメント別分析
    • 大腸がん（Colorectal Cancer
    • 乳がん

第8章 肝転移治療薬の世界市場：流通チャネル別

  • マーケットスナップショット
  • 肝転移治療薬の世界市場：流通チャネル別、パフォーマンス-ポテンシャル分析
  • 肝転移治療薬の世界市場推定・予測（流通チャネル別） 2019-2029
  • 肝転移治療薬市場、サブセグメント別分析
    • 病院内薬局
    • スペシャリティファーマシー

第9章 肝転移治療薬の世界市場：地域別分析

  • 肝転移治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • 原発がん別の推定・予測、2019年～2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州肝転移治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の肝転移治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ肝転移治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • AstraZeneca
    • Bayer AG
    • Eli Lilly and Company
    • Ono Pharmaceutical
    • Pfizer, Inc.
    • Bristol-Myers Squibb Company
    • Cadila Pharmaceuticals Ltd.
    • Biocare Medical, LLC
    • Foundation Medicine, Inc.

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Liver Metastases Treatment Market, report scope
  • TABLE 2. Global Liver Metastases Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Liver Metastases Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Liver Metastases Treatment Market estimates & forecasts by Primary Cancer 2019-2029 (USD Billion)
  • TABLE 5. Global Liver Metastases Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Liver Metastases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Liver Metastases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Liver Metastases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Liver Metastases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Liver Metastases Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Liver Metastases Treatment Market, research methodology
  • FIG 2. Global Liver Metastases Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Liver Metastases Treatment Market, key trends 2021
  • FIG 5. Global Liver Metastases Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Liver Metastases Treatment Market, porters 5 force model
  • FIG 7. Global Liver Metastases Treatment Market, pest analysis
  • FIG 8. Global Liver Metastases Treatment Market, value chain analysis
  • FIG 9. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Liver Metastases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Liver Metastases Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Liver Metastases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Liver Metastases Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Liver Metastases Treatment Market is valued at approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2022-2029. Liver Metastases are spread from an original Tumor or cancer to the liver. Liver Metastases do not begin with the Liver, they spread from other affected body parts. Cancers that spread to the liver cause Liver Metastases. Liver Metastases Treatment is the method used to cure Liver Metastases. Some of the common cancers that spread to the liver are breast cancer, colorectal cancer, esophageal cancer, and lung cancer. Increasing cases of breast and colorectal cancer, increasing government support and initiatives in cancer treatment, growing research and development, and rising incidence of target disease are the factors driving the growth of the market.

According to the World Cancer Research Fund, the global number of breast cancer cases was around 12.5% in the year 2020, whereas Lung cancer cases were around 12.2% in the same year. With 1.9 million new cases in 2020, colorectal cancer ranked third among all cancer types and accounted for 10.7% of all cases. Additionally, World Health Organisation unveiled a new global breast cancer initiative framework in February 2023, to achieve the goal of preventing 2.5 million deaths from breast cancer by 2040. The increasing cases of breast and colorectal cancer and increasing government support and initiatives are the major factors driving the growth of the market. Other important components driving market increase are growing research and development and the rising incidence of the target disease. Technological advancements in Liver Metastases Treatment and increasing R&D in healthcare are creating major market opportunities in the forecast period. However, the high cost of Liver Metastases Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Liver Metastases Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced treatment options for cancer, favorable government policies for cancer, and the high prevalence of liver metastases in the country such as the US. For instance, there are around 140,000 liver metastases cases annually in the US. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing healthcare expenditure, easy access to healthcare facilities, and lack of effective screening practices in the region.

Major market players included in this report are:

  • F. Hoffmann - La Roche Ltd.
  • AstraZeneca
  • Bayer AG
  • Eli Lilly and Company
  • Ono Pharmaceutical
  • Pfizer, Inc.
  • Bristol - Myers Squibb Company
  • Cadila Pharmaceuticals Ltd.
  • Biocare Medical, LLC
  • Foundation Medicine, Inc.

Recent Developments in the Market:

  • In March 2020, Nivolumab and ipilimumab were given rapid approval by the Food and Drug Administration to Ono Pharmaceuticals for the treatment of patients with hepatocellular carcinoma (HCC) who had previously been diagnosed with sorafenib.
  • In May 2020, atezolizumab and bevacizumab have been given FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC) who have not had any prior systemic therapy.

Global Liver Metastases Treatment Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Primary Cancer, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy

By Primary Cancer:

  • Colorectal Cancer
  • Breast Cancer

By Distribution Channel:

  • Hospital Pharmacies
  • Specialty Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Liver Metastases Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Liver Metastases Treatment Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Liver Metastases Treatment Market, by Primary Cancer, 2019-2029 (USD Billion)
    • 1.2.4. Liver Metastases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Liver Metastases Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Liver Metastases Treatment Market Dynamics

  • 3.1. Liver Metastases Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of breast and colorectal cancer
      • 3.1.1.2. Increasing government support and initiatives in cancer treatment
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Liver Metastases Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in Liver Metastases Treatment
      • 3.1.3.2. Increasing R&D in healthcare

Chapter 4. Global Liver Metastases Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Liver Metastases Treatment Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Liver Metastases Treatment Market by Type, Performance - Potential Analysis
  • 6.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Targeted Therapy
    • 6.4.3. Immunotherapy

Chapter 7. Global Liver Metastases Treatment Market, by Primary Cancer

  • 7.1. Market Snapshot
  • 7.2. Global Liver Metastases Treatment Market by Primary Cancer, Performance - Potential Analysis
  • 7.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Primary Cancer 2019-2029 (USD Billion)
  • 7.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 7.4.1. Colorectal Cancer
    • 7.4.2. Breast Cancer

Chapter 8. Global Liver Metastases Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Liver Metastases Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Liver Metastases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Liver Metastases Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Specialty Pharmacies

Chapter 9. Global Liver Metastases Treatment Market, Regional Analysis

  • 9.1. Liver Metastases Treatment Market, Regional Market Snapshot
  • 9.2. North America Liver Metastases Treatment Market
    • 9.2.1. U.S. Liver Metastases Treatment Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Primary Cancer breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Liver Metastases Treatment Market
  • 9.3. Europe Liver Metastases Treatment Market Snapshot
    • 9.3.1. U.K. Liver Metastases Treatment Market
    • 9.3.2. Germany Liver Metastases Treatment Market
    • 9.3.3. France Liver Metastases Treatment Market
    • 9.3.4. Spain Liver Metastases Treatment Market
    • 9.3.5. Italy Liver Metastases Treatment Market
    • 9.3.6. Rest of Europe Liver Metastases Treatment Market
  • 9.4. Asia-Pacific Liver Metastases Treatment Market Snapshot
    • 9.4.1. China Liver Metastases Treatment Market
    • 9.4.2. India Liver Metastases Treatment Market
    • 9.4.3. Japan Liver Metastases Treatment Market
    • 9.4.4. Australia Liver Metastases Treatment Market
    • 9.4.5. South Korea Liver Metastases Treatment Market
    • 9.4.6. Rest of Asia Pacific Liver Metastases Treatment Market
  • 9.5. Latin America Liver Metastases Treatment Market Snapshot
    • 9.5.1. Brazil Liver Metastases Treatment Market
    • 9.5.2. Mexico Liver Metastases Treatment Market
  • 9.6. Rest of The World Liver Metastases Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. F. Hoffmann - La Roche Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca
    • 10.2.3. Bayer AG
    • 10.2.4. Eli Lilly and Company
    • 10.2.5. Ono Pharmaceutical
    • 10.2.6. Pfizer, Inc.
    • 10.2.7. Bristol - Myers Squibb Company
    • 10.2.8. Cadila Pharmaceuticals Ltd.
    • 10.2.9. Biocare Medical, LLC
    • 10.2.10. Foundation Medicine, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption